Frederick R. Ueland

Also affiliated with Markey Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy”.

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy

Cancers(2022)10.3390/cancers14092220

N/A

0.753DataRank · unranked

150 citations

Annabel M. McAtee, Khaga R. Neupane, Christopher I. Richards, Frederick R. Ueland, Jill Kolesar +1 more

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279

Journal of Clinical Oncology(2024)10.1200/jco.23.02235

N/A

0.637DataRank · unranked

19 citations

Wei Deng, I. Peterson, Robert S. Mannel, J. S. Thompson, Elizabeth Lokich +12 more

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells

Diagnostics(2020)10.3390/diagnostics10020121

N/A

0.574DataRank · unranked

45 citations

Abigail Anderson, J. Robert McCorkle, Jianrong Wu, Frederick R. Ueland, Jill Kolesar +1 more

Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice

Cancers(2023)10.3390/cancers15123192

N/A

0DataRank · unranked

4 citations

Heather Pavlik, Ning Li, Lien Qasrawi, Donglin Yan, Justine Pickarski +5 more

Clinical utility of reporting research genetic predisposition testing results to Total Cancer Care participants.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10602

N/A

0DataRank · unranked

0 citations

Shulin Zhang, Nan Lin, Justine Pickarski, Sainan Wei, Rachel W. Miller +7 more

Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports

JCO Precision Oncology(2024)10.1200/po.24.00301

N/A

0DataRank · unranked

4 citations

James P. Collard, Ning Li, Donglin Yan, Charles S. Dietrich, Rachel W. Miller +4 more

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.003

N/A

0DataRank · unranked

9 citations

Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle +15 more

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer

PLoS ONE(2021)10.1371/journal.pone.0254205

N/A

0DataRank · unranked

27 citations

J Górski, Jinpeng Liu, M.B. Riggs, Anthony McDowell, Nan Lin +4 more

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment

Frontiers in Oncology(2023)10.3389/fonc.2022.1042730

N/A

0DataRank · unranked

35 citations

Namrata Anand, Abigail Anderson, J. Robert McCorkle, Khaga R. Neupane, Alexandra N. Nail +6 more